Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin
- PMID: 1553339
- DOI: 10.1023/a:1018925004345
Cutaneous metabolism of nitroglycerin in vitro. I. Homogenized versus intact skin
Abstract
The metabolism of nitroglycerin (GTN) to 1,2- and 1,3-glyceryl dinitrate (GDN) by hairless mouse skin in vitro has been measured. In the first set of experiments, GTN was incubated with the 9000g supernatant of fresh, homogenized tissue in the presence and absence of glutathione (GSH), a cofactor for glutathione-S-transferase. After 2 hr of incubation with GSH, 30% of the initially present GTN had been converted to 1,2- and 1,3-GDN; without GSH, less than 5% of the GTN was metabolized. The ratio of 1,2-GDN to 1,3-GDN produced by the homogenate was 1.8-2.1. In the second series of studies, GTN was administered topically to freshly excised, intact hairless mouse skin in conventional in vitro diffusion cells. The concurrent transport and metabolism of GTN was then monitored by sequential analysis of the receptor phase perfusing the dermal side of the tissue. Three topical formulations were used: a low concentration (1 mg/ml) aqueous solution, a 2% ointment, and a transdermal delivery system. Delivery of total nitrates (GTN + 1,2-GDN + 1,3-GDN) into the receptor phase was similar for ointment and patch formulations and much greater than that from the solution. The percentage metabolites formed, however, was greatest for the solution (61% and 2 hr, compared to 49% for the patch and 35% for the ointment). As has been noted before, therefore, the relative level of skin metabolism is likely to be greatest when the transepidermal flux is small. Distinct from the homogenate experiments, the 1,2/1,3-GDN ratios in the penetration studies were in the range 0.7-0.9.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement.Pharm Res. 1992 Mar;9(3):303-6. doi: 10.1023/a:1015822431178. Pharm Res. 1992. PMID: 1614960
-
Percutaneous penetration kinetics of nitroglycerin and its dinitrate metabolites across hairless mouse skin in vitro.Pharm Res. 1991 Oct;8(10):1231-7. doi: 10.1023/a:1015887309391. Pharm Res. 1991. PMID: 1796039
-
Differential biotransformation of glyceryl trinitrate by red blood cell-supernatant fraction and pulmonary vein homogenate.Can J Physiol Pharmacol. 1989 May;67(5):417-22. doi: 10.1139/y89-066. Can J Physiol Pharmacol. 1989. PMID: 2504466
-
Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.Clin Pharmacokinet. 2003;42(3):205-21. doi: 10.2165/00003088-200342030-00001. Clin Pharmacokinet. 2003. PMID: 12603173 Review.
-
Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase.Trends Cardiovasc Med. 2006 Nov;16(8):259-65. doi: 10.1016/j.tcm.2006.05.001. Trends Cardiovasc Med. 2006. PMID: 17055381 Review.
Cited by
-
Selegiline percutaneous absorption in various species and metabolism by human skin.Pharm Res. 1997 Jan;14(1):50-5. doi: 10.1023/a:1012051300130. Pharm Res. 1997. PMID: 9034220
-
Cutaneous metabolism of nitroglycerin in vitro. II. Effects of skin condition and penetration enhancement.Pharm Res. 1992 Mar;9(3):303-6. doi: 10.1023/a:1015822431178. Pharm Res. 1992. PMID: 1614960
-
Development of an on-animal separation-based sensor for monitoring drug metabolism in freely roaming sheep.Analyst. 2015 Jun 7;140(11):3820-9. doi: 10.1039/c4an01928h. Analyst. 2015. PMID: 25697221 Free PMC article.
-
Xenobiotic bioconversion in human epidermis models.Pharm Res. 2003 Aug;20(8):1113-8. doi: 10.1023/a:1025024309223. Pharm Res. 2003. PMID: 12948006 Review.
-
Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.J Pharm Sci. 2013 Sep;102(9):3070-81. doi: 10.1002/jps.23550. Epub 2013 May 13. J Pharm Sci. 2013. PMID: 23670666 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials